Sort
15,440 grants matching “organoids”
In-situ architecture of membrane contact sites mediating organelle fission
$921,476Shyamal Mosalaganti · University Of Michigan At Ann Arbor · DP2 · FY2025 · GM
Characterization Unit
$920,319David Liu · Dana-Farber Cancer Inst · U2C · FY2021 · CA
Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
$919,535Rohit N. Kulkarni · Joslin Diabetes Center · U01 · FY2023 · DK
Biocontainment Research support services core
$919,306Farhang Alem · George Mason University · UC7 · FY2024 · AI
Identifying and targeting collateral lethal vulnerabilities in cancers
$918,686Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · U01 · FY2024 · CA
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms
$917,988Calvin J Kuo · Stanford University · U01 · FY2019 · CA
Intestinal Organoids as a model system for studying enteric disease
$916,571Alison A. Weiss · University Of Cincinnati · U19 · FY2018 · AI
Intestinal Organoids as a model system for studying enteric disease
$916,571Alison A. Weiss · University Of Cincinnati · U19 · FY2019 · AI
Intestinal Organoids as a model system for studying enteric disease
$916,571Alison A. Weiss · University Of Cincinnati · U19 · FY2017 · AI
Intestinal Organoids as a model system for studying enteric disease
$916,571Alison A. Weiss · University Of Cincinnati · U19 · FY2016 · AI
Exploring the Pathophysiology of AD and ADRDs with 3D Asteroid Models
$916,247Benjamin L Wolozin · Boston University Medical Campus · R56 · FY2021 · AG
Gastroesophageal junction stem cells as the origin of Barretts esophagus and cancer
$915,767Timothy Cragin Wang · Columbia University Health Sciences · R01 · FY2024 · CA
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
$915,166Joel S. Bader · Johns Hopkins University · U01 · FY2017 · CA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$913,866Mary Christine Playdon · University Of Utah · U01 · FY2022 · CA
Aberrant protein S-nitrosylation mediates Gene-Environment Interactions in AD/ADRD
$913,756Stuart A Lipton · Scripps Research Institute, The · U01 · FY2024 · AG
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
$913,659Christopher Eldridge Sims · Altis Biosystems, Inc. · R44 · FY2024 · TR
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
$913,659Bill Thelin · Altis Biosystems, Inc. · R44 · FY2023 · TR
Proteogenomics of Splicing Proteinopathies in Neurodegeneration
$913,225Junmin Peng · St. Jude Children'S Research Hospital · R01 · FY2025 · AG
Continuous Neurogenesis in the Mammalian Hippocampus
$912,690Hongjun Song · University Of Pennsylvania · R35 · FY2024 · NS
Identification, Quantification, and Functional Characterization of Transporters in Human Placenta, Developing Gut and Fetal Brain
$912,344Joanne Wang · University Of Washington · UC2 · FY2024 · HD
CELL EXPANSION BIOREACTORS FOR ASSAY-READY IMMUNOCOMPETENT PATIENT MODELS
$911,110Kacey Ronaldson · Link Biosystems Inc. · R44 · FY2025 · CA
Functional Analysis of Oncogenic Networks in Primary Organoids
$909,785Calvin J Kuo · Stanford University · U01 · FY2016 · CA
Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer
$908,985Sandra W Ryeom · Columbia University Health Sciences · R01 · FY2023 · CA
Understanding Schizophrenia Risk Mechanisms Via Multimodal Analysis of Patient-derived Neurons and 3D Cortical Organoids and Correlation with Clinical and Cognitive Phenotypes
$908,174Brady J Maher · Lieber Institute, Inc. · R01 · FY2024 · MH
Cancer and Context
$907,927Ian G Macara · Vanderbilt University · R35 · FY2019 · CA